JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Sees Large Decline in Short Interest

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) saw a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 459,300 shares, a decrease of 9.0% from the December 31st total of 505,000 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

JCR Pharmaceuticals Stock Performance

Shares of OTCMKTS JCRRF opened at $4.57 on Monday. The stock’s 50-day moving average is $4.57 and its two-hundred day moving average is $4.54. JCR Pharmaceuticals has a 1-year low of $4.30 and a 1-year high of $4.70.

About JCR Pharmaceuticals

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.